CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P14
Within normal range
vs 5Y Ago
-254.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | -1496.97% | +81.0% |
| 2024 | -7882.21% | +45.0% |
| 2023 | -14343.14% | - |
| 2022 | 0.00% | -100.0% |
| 2021 | 2.53% | -56.9% |
| 2020 | 5.88% | +41.4% |
| 2019 | 4.16% | -67.9% |
| 2018 | 12.93% | +50.9% |
| 2017 | 8.57% | +21.8% |
| 2016 | 7.04% | - |